Insto's probably look at Alcidion and lump them into the same...

Insto's probably look at Alcidion and lump them into the same basket as the dominant US players and, as is their want, glibly "Look at what they are up against" in the sticky world of digital healthcare... a case of recurring know-thy-familiarity..

As retail shareholders we have made ourselves aware of the Alcidion product suite and recognise that it is complementary to the entrenched big boys, and in several ways, adds value to the existing systems in place.

It's these points-of-difference, value-adds, that the insto's have yet to acknowledge...somehow Alcidion has to go hard in educating the suits of same.